Diodone
Chemical compound
- V08AA10 (WHO)
- (3,5-Diiodo-4-oxo-1(4H)-pyridinyl)acetic acid
- 101-29-1
Y
- 9304
- DB13568
- 8945
- NLX9TZ649P
- DG01178
- DTXSID7043794
![Edit this at Wikidata](http://upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/10px-OOjs_UI_icon_edit-ltr-progressive.svg.png)
- Interactive image
- O=C(O)CN/1/C=C(/I)C(=O)C(\I)=C\1
InChI
- InChI=1S/C7H5I2NO3/c8-4-1-10(3-6(11)12)2-5(9)7(4)13/h1-2H,3H2,(H,11,12)
- Key:PVBALTLWZVEAIO-UHFFFAOYSA-N
Diodone is a radiocontrast agent that was used in urography.[1] It was usually formulated as a salt with diethanolamine.
See also
- Iodinated contrast
References
- ^ Wilson DM, Apter JT, Schwartz FD (January 1970). "A model for measuring renal blood flow from plasma disappearance of iodopyracet". Journal of Applied Physiology. 28 (1): 79–88. doi:10.1007/BF00698048. PMID 5409794. S2CID 9165082.
- v
- t
- e
Contrast media (V08)
Iodinated, Water soluble |
| ||||||
---|---|---|---|---|---|---|---|
Iodinated, Water insoluble |
| ||||||
Non-iodinated |
Paramagnetic | |
---|---|
Superparamagnetic |
|
Other |
- Microspheres of human albumin
- Microparticles of galactose
- Perflenapent
- Microspheres of phospholipids
- Sulfur hexafluoride
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
![]() | This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e